485 related articles for article (PubMed ID: 15282233)
21. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
22. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
23. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
24. [Management of TB suspected cases of drug resistant tuberculosis requiring a second treatment].
Caminero JA
Biomedica; 2004 Jun; 24 Supp 1():212-27. PubMed ID: 15495588
[TBL] [Abstract][Full Text] [Related]
25. Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases.
Jimenez-Arellanes A; Meckes M; Ramirez R; Torres J; Luna-Herrera J
Phytother Res; 2003 Sep; 17(8):903-8. PubMed ID: 13680821
[TBL] [Abstract][Full Text] [Related]
26. Drug resistance profile of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Jos, Nigeria.
Ani AE; Idoko J; Dalyop YB; Pitmang SL
Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):67-71. PubMed ID: 18789463
[TBL] [Abstract][Full Text] [Related]
27. Management of drug-resistant tuberculosis.
Chiang CY; Schaaf HS
Int J Tuberc Lung Dis; 2010 Jun; 14(6):672-82. PubMed ID: 20487603
[TBL] [Abstract][Full Text] [Related]
28. Treatment of multidrug-resistant tuberculosis during pregnancy: a report of 7 cases.
Shin S; Guerra D; Rich M; Seung KJ; Mukherjee J; Joseph K; Hurtado R; Alcantara F; Bayona J; Bonilla C; Farmer P; Furin J
Clin Infect Dis; 2003 Apr; 36(8):996-1003. PubMed ID: 12684912
[TBL] [Abstract][Full Text] [Related]
29. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
Matee M; Mfinanga S; Holm-Hansen C
APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
[TBL] [Abstract][Full Text] [Related]
30. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
31. Evidence of 'amplifier effect' in pulmonary multidrug-resistant tuberculosis: report of three cases.
Umubyeyi A; Shamputa IC; Rigouts L; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2007 Nov; 11(6):508-12. PubMed ID: 17376726
[TBL] [Abstract][Full Text] [Related]
32. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
Caminero JA
Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
[TBL] [Abstract][Full Text] [Related]
33. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
34. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F
Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290
[TBL] [Abstract][Full Text] [Related]
35. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Yamada H; Mitarai S
Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
[TBL] [Abstract][Full Text] [Related]
36. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
Sneag DB; Schaaf HS; Cotton MF; Zar HJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
[TBL] [Abstract][Full Text] [Related]
37. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice.
Matsumoto M; Hashizume H; Tomishige T; Kawasaki M; Tsubouchi H; Sasaki H; Shimokawa Y; Komatsu M
PLoS Med; 2006 Nov; 3(11):e466. PubMed ID: 17132069
[TBL] [Abstract][Full Text] [Related]
38. Management of multi-drug resistant tuberculosis: practitioner's view point.
Prasad R
Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterium tuberculosis: drug resistance and future perspectives.
Riccardi G; Pasca MR; Buroni S
Future Microbiol; 2009 Jun; 4(5):597-614. PubMed ID: 19492969
[TBL] [Abstract][Full Text] [Related]
40. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
